Krystal Biotech Inc (KRYS)

Cost of Revenue

$29.34M

TTM · Period ending: · USD

KRYS logo

KRYS Cost of Revenue

Latest reported$29.34M
KRYS TTM Cost of Revenue ($0.00 → $29.34M)
High-resolution chart · PNG

KRYS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Krystal Biotech Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
29,340,000
30,068,000
28,773,000
22,805,000
23,826,000
22,670,000
20,061,000
19,490,000
13,029,000
7,020,000
4,601,000
223,000
0
0
1,014,999
1,014,999
1,014,999
1,014,999
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.